Malignancy

Immunology·MeSH: Lymphadenopathy

42 drugs in development·20 companies·2 clinical trials

Drug Pipeline by Phase

Approved(9)

Drug	Company
calcitonin-salmon	Amneal Pharmaceuticals, Inc. (AMRX)
cefepime	Seagen Inc. (SGEN)
cefepime	Atara Biotherapeutics, Inc. (ATRA)
fludeoxyglucose f18	BRIGHT MINDS BIOSCIENCES INC. (DRUG)
fludeoxyglucose f18	Cardinal Health Inc. (CAH)
ova1	Aspira Women's Health Inc. (AWHL)
ovawatch	Aspira Women's Health Inc. (AWHL)
overa	Aspira Women's Health Inc. (AWHL)
zoledronic acid	Amneal Pharmaceuticals, Inc. (AMRX)

Phase 3(15)

Drug	Company
bg-75202	BeOne Medicines Ltd. (ONC)
BG-75202	BeOne Medicines Ltd. (ONC)
bgb-16673	BeOne Medicines Ltd. (ONC)
BGB-16673	BeOne Medicines Ltd. (ONC)
dabrafenib	GH Research PLC (GHRS)
fludarabine phosphate	Filana Therapeutics Inc. (FLNA)
mosunetuzumab	BeOne Medicines Ltd. (ONC)
Mosunetuzumab	BeOne Medicines Ltd. (ONC)
obinutuzumab	BeOne Medicines Ltd. (ONC)
obinutuzumab	BeOne Medicines Ltd. (ONC)
Obinutuzumab	BeOne Medicines Ltd. (ONC)
pelabresib	Novartis AG (NVS)
sonrotoclax	BeOne Medicines Ltd. (ONC)
Sonrotoclax	BeOne Medicines Ltd. (ONC)
trametinib	GH Research PLC (GHRS)

Phase 2(5)

Drug	Company
Aldesleukin	Filana Therapeutics Inc. (FLNA)
emavusertib	CURIS INC (CRIS)
Emavusertib (CA-4948)	CURIS INC (CRIS)
incb059872	Incyte Corp. (INCY)
Individual Patient TCR-Transduced PBL	Filana Therapeutics Inc. (FLNA)

Phase 1(10)

Drug	Company
ABT-263	AbbVie Inc. (ABBV)
ADI-270	Adicet Bio, Inc. (ACET)
Autologous CCR4 CAR T cells	Filana Therapeutics Inc. (FLNA)
Autologous CCR4 CAR T cells	Merus N.V. (MRUS)
CTX110	CRISPR Therapeutics AG (CRSP)
fhd-286	Foghorn Therapeutics Inc. (FHTX)
hypomethylation agent	BeOne Medicines Ltd. (BEIGF)
hypomethylation agent	BeOne Medicines Ltd. (ONC)
low dose cytarabine	Foghorn Therapeutics Inc. (FHTX)
thymoglobulin	GH Research PLC (GHRS)

Preclinical(1)

Drug	Company
Parathyroid Hormone Antagonist Program	Crinetics Pharmaceuticals, Inc. (CRNX)

Phase 1/Phase 2(2)

Drug	Company
all-trans retinoic acid	Incyte Corp. (INCY)
mrtx1719	Mirati Therapeutics, Inc. (MRTX)

BioSniper tracks 42 drugs in development for Malignancy across 20 companies.

There are 2 clinical trials targeting Malignancy tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.